Novo CEO pressed by Senate to chop costs of weight problems, diabetes drugs CEO Lars Fruergaard Jørgensen instructed lawmakers the corporation would contemplate new talks with insurers in regards to the record charges of Wegovy and copyright if they pledge to help keep the medicines on their formularies. The deal https://kethek.com/